Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Glaucoma: Overview01:25

Glaucoma: Overview

548
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
548
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

430
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
430
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

479
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
479

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

ZNRF3 and RNF43 are active monomeric E3 ubiquitin ligases that self-associate.

Science signaling·2026
Same author

AB-MDMSBA-Not a Synthetic Cannabinoid Receptor Agonist.

Pharmacology research & perspectives·2026
Same author

Retinal Ganglion Cell Degeneration in Glaucoma: Systematic Review.

Bioengineering (Basel, Switzerland)·2026
Same author

HSR26-214: Impact of Upper Gastrointestinal Bleeding on Mortality and Healthcare Utilization in Gastric Cancer Patients: A Real-World Evidence Analysis from the 2021 NIS Dataset.

Journal of the National Comprehensive Cancer Network : JNCCN·2026
Same author

HSR26-214: Impact of Upper Gastrointestinal Bleeding on Mortality and Healthcare Utilization in Gastric Cancer Patients: A Real-World Evidence Analysis from the 2021 NIS Dataset.

Journal of the National Comprehensive Cancer Network : JNCCN·2026
Same author

Ahmed shunt extrusion through prior penetrating keratoplasty graft.

Eye (London, England)·2026
Same journal

Correction: Komatsu et al. Three-Dimensional Visualization and Detection of the Pulmonary Venous-Left Atrium Connection Using Artificial Intelligence in Fetal Cardiac Ultrasound Screening. <i>Bioengineering</i> 2026, <i>13</i>, 100.

Bioengineering (Basel, Switzerland)·2026
Same journal

Comparison of CO<sub>2</sub> Laser and Microdebrider in the Surgical Treatment of Pediatric Recurrent Respiratory Papillomatosis: A Retrospective Analysis.

Bioengineering (Basel, Switzerland)·2026
Same journal

Toward More Translational Tumor Models: Breast dECM-Based 3D Systems Capture Native Microenvironmental Cues.

Bioengineering (Basel, Switzerland)·2026
Same journal

Postural Stability Changes During the 4 Phases of the Half Squat: Kinematics Profile of the Center of Pressure and Center of Mass in High-Performance Weightlifters-A Pilot Study.

Bioengineering (Basel, Switzerland)·2026
Same journal

Definite Implant Position as Novel Readout for Effectiveness of Ridge Preservation Indicates to Beneficial Effect of Combined Treatment with Platelet-Rich Fibrin (PRF) and Xenogenic Biomaterial in Bone Regeneration.

Bioengineering (Basel, Switzerland)·2026
Same journal

Trueness and Precision of Intraoral Scanners for 3D-Printed Orthodontic Models with Attachments: An In Vitro Comparative Study.

Bioengineering (Basel, Switzerland)·2026
See all related articles

Related Experiment Video

Updated: Jun 25, 2025

A Model of Glaucoma Induced by Circumlimbal Suture in Rats and Mice
07:00

A Model of Glaucoma Induced by Circumlimbal Suture in Rats and Mice

Published on: October 5, 2018

10.4K

Wound Modulations in Glaucoma Surgery: A Systematic Review.

Bhoomi Dave1,2, Monica Patel1, Sruthi Suresh1

  • 1Department of Ophthalmology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.

Bioengineering (Basel, Switzerland)
|May 25, 2024
PubMed
Summary
This summary is machine-generated.

Glaucoma surgery success is limited by scar tissue formation, impacting intraocular pressure (IOP) control. Novel anti-fibrotic treatments are needed for better surgical outcomes and reduced toxicity.

Keywords:
anti-LOXL2 monoclonal Abanti-vascular endothelial growth factorsantifibrotic agentscytokine inhibitorsglaucoma surgerygrowth factor inhibitorsintegrin inhibitorswound healing

More Related Videos

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents
10:10

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents

Published on: February 15, 2022

1.4K
Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation
08:30

Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation

Published on: March 12, 2016

13.1K

Related Experiment Videos

Last Updated: Jun 25, 2025

A Model of Glaucoma Induced by Circumlimbal Suture in Rats and Mice
07:00

A Model of Glaucoma Induced by Circumlimbal Suture in Rats and Mice

Published on: October 5, 2018

10.4K
Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents
10:10

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents

Published on: February 15, 2022

1.4K
Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation
08:30

Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation

Published on: March 12, 2016

13.1K

Area of Science:

  • Ophthalmology
  • Surgical Innovation
  • Wound Healing Research

Background:

  • Glaucoma surgery efficacy is often compromised by excessive fibrosis, leading to poor intraocular pressure (IOP) control.
  • Current anti-fibrotic agents like mitomycin C (MMC) and 5-fluorouracil (5-FU) have unpredictable outcomes and potential toxicity.

Purpose of the Study:

  • To review the pathophysiology of wound healing in glaucoma surgery.
  • To explore current and novel anti-fibrotic agents for improved surgical outcomes.
  • To identify treatments offering better IOP control with reduced toxicity.

Main Methods:

  • Literature review of wound healing mechanisms in glaucoma surgery.
  • Analysis of existing anti-fibrotic therapies (MMC, 5-FU).
  • Evaluation of emerging and future therapeutic agents targeting fibrosis.

Main Results:

  • Fibrosis remains a significant challenge in glaucoma surgery, reducing long-term success.
  • Existing treatments show limitations in efficacy and predictability.
  • Novel agents show promise for more targeted and effective fibrosis management.

Conclusions:

  • There is a critical need for advanced anti-fibrotic strategies in glaucoma surgery.
  • Future treatments should focus on enhanced specificity and reduced toxicity for improved IOP management.
  • Further research into novel wound healing agents is essential for advancing glaucoma surgical care.